Tuesday, September 16, 2014

Fwd: CDER New September 16, 2014


---------- Forwarded message ----------
From: U.S. Food & Drug Administration (FDA) <fda@service.govdelivery.com>
Date: Tue, Sep 16, 2014 at 7:17 AM
Subject: CDER New September 16, 2014
To: iammejtm@gmail.com


FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

September 15, 2014


New and Generic Drug Approvals

September 12, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Advil Liqui-Gels ibuprofen Capsule;Oral Pfizer Manufacturing Change or Addition
Advil Migraine Liqui-Gels ibuprofen Capsule;Oral Pfizer Manufacturing Change or Addition
Afinitor everolimus Tablet;Oral Novartis Manufacturing Change or Addition
Allegra Allergy fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Allegra Hives fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Amlodipine and Valsartan amlodipine;valsartan Tablet;Oral Torrent Pharms Ltd Tentative Approval
An-Sulfur Colloid technetium tc-99m sulfur colloid kit Solution;Injection, Oral Pharmalucence Manufacturing Change or Addition
Children's Allegra Allergy fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Children's Allegra Hives fexofenadine hydrochloride Tablet;Oral Sanofi Aventis Us Labeling Revision
Clindamycin Phosphate and Benzoyl Peroxide benzoyl peroxide; clindamycin phosphate Gel;Topical Mylan Pharms Inc Manufacturing Change or Addition
Daptomycin daptomycin Injectable;Injection Hospira Inc Approval
Emtricitabine;Tenofovir Disoproxil Fumarate;Nevirapine emtricitabine;tenofovir disoproxil fumarate;nevirapine Tablet;Oral Mylan Labs Ltd Tentative Approval
Forteo teriparatide recombinant human Injectable;Subcutaneous Lilly Manufacturing Change or Addition
Glycine 1.5% In Plastic Container glycine Solution;Irrigation B Braun Manufacturing Change or Addition
Humalog insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Kwikpen insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 50/50 insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 50/50 Kwikpen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 50/50 Pen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 75/25 insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 75/25 Kwikpen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Mix 75/25 Pen insulin lispro protamine recombinant; insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humalog Pen insulin lispro recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humatrope somatropin recombinant Injectable;Injection Lilly Manufacturing Change or Addition
Humulin 70/30 insulin recombinant human; insulin susp isophane recombinant human Injectable;Injection Lilly Manufacturing Change or Addition
Humulin 70/30 Pen insulin recombinant human; insulin susp isophane recombinant human Injectable;Injection Lilly Manufacturing Change or Addition
Humulin N insulin susp isophane recombinant human Injectable;Injection Lilly Manufacturing Change or Addition
Mycophenolate Mofetil mycophenolate mofetil Capsule;Oral Roxane Manufacturing Change or Addition
Mycophenolate Mofetil mycophenolate mofetil Tablet;Oral Roxane Manufacturing Change or Addition
Naprelan naproxen sodium Tablet, Extended Release;Oral Almatica Pharma Inc Manufacturing Change or Addition
Pomalyst pomalidomide Capsule;Oral Celgene Labeling Revision
Revlimid lenalidomide Capsule;Oral Celgene Labeling Revision
Thalomid thalidomide Capsule;Oral Celgene Supplement
Vibra-Tabs doxycycline hyclate Tablet;Oral Pfizer Labeling Revision
Vibramycin doxycycline For Suspension;Oral Pfizer Labeling Revision
Vibramycin doxycycline hyclate Capsule;Oral Pfizer Labeling Revision
Vibramycin doxycycline calcium Suspension;Oral Pfizer Labeling Revision
Zoloft sertraline hydrochloride Tablet;Oral Pfizer Labeling Revision
Zoloft sertraline hydrochloride Concentrate;Oral Pfizer Labeling Revision

 


FDA Logo

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:
Visit Us on Facebook Visit Us on Twitter Visit Us on YouTube Sign up for email updates Visit Us on Flickr Visit Our Blog  

This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery



--
Jeremy Tobias Matthews

No comments:

Post a Comment